本页面由Tiger Trade Technology Pte. Ltd.提供服务

Atrium Therapeutics

6.64
+0.16002.47%
盘后:6.640.00000.00%16:20 EST
成交量:22.08万
成交额:147.34万
市值:1.43亿
市盈率:-1.55
高:6.78
开:6.46
低:6.45
收:6.48
52周最高:16.77
52周最低:6.36
股本:2,157.15万
流通股本:1,950.94万
量比:0.84
换手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-4.2815
每股收益(LYR):-3.1905
净资产收益率:-94.98%
总资产收益率:-34.82%
市净率:0.70
市盈率(LYR):-2.08

数据加载中...

2026/11/16

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/12

重要事件披露

Form 8-K - Current report
2026/11/02

重要事件披露

Form 8-K - Current report
2026/10/27

重要事件披露

Form 8-K - Current report
2026/10/09

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/10/08

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/14

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/04/27

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/08

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors